Novartis reported $30.21B in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
AstraZeneca AZN:LN 22594M 1055M
Canopy Growth Corp WEED:CN C$ 239.25M 20.66M
Corcept Therapeutics CORT:US $ 47.54M 2.78M
Novartis NOVN:VX SF 30208M 328M
Valeant Pharmaceuticals VRX:CN $ 5198M 239M
Zoetis ZTS:US $ 1797M 326M